Try our Advanced Search for more refined results

October 18, 2019

Wheby v. Dova Pharmaceuticals, Inc. et al

Track this case

Case Number:

1:19-cv-01981

Court:

Delaware

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Leonard P. Stark

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 18, 2019

    Dova Pharma Hit With Investor Suit Over $915M Sobi Tie-Up

    A Dova Pharmaceuticals Inc. investor filed a proposed class action Friday in Delaware federal court asserting the company has violated securities laws by not filing enough information about its proposed $915 million tie-up with biopharmaceutical company Swedish Orphan Biovitrum.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login